CPhi Preview 2013: Ashland - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhi Preview 2013: Ashland


Untitled Document

2013 CPhI Exhibitor Preview

Company: Ashland Inc.

Description: Ashland Specialty Ingredients offers an unparalleled range of cellulosic and vinyl pyrrolidone polymers to meet the needs of pharmaceutical and nutraceutical formulators. Ashland is the full-service solid-dosage resource for tablet binding, film coating and disintegration; as well as excipients for controlled release and drug solubilization. To learn more, visit ashland.com/pt/pharmaceutical.

Website: ashland.com/pt/pharmaceutical

Booth Number: Hall 6.1, Booth 61B38

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here